Profusa (PFSA) Stock Price

Profusa Price

NASDAQ·CLOSED
0.41
​
Market closed

Profusa stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profusa business model & stock analysis

NorthView Acquisition Corp. makes money by effecting business combinations such as mergers, share exchanges, or asset acquisitions with healthcare-focused businesses. The company targets healthcare businesses for potential acquisitions, aiming to create value through strategic partnerships. It operates as a blank check company with no current business operations or revenue generation. The firm has no full-time employees and was formed to pursue a merger or similar transaction. It is headquartered in New York City and went public via IPO on December 20, 2021. NorthView Acquisition Corp. does not generate revenue from its own operations but seeks to profit from successful business combinations with target companies. The company focuses exclusively on healthcare businesses for its acquisition strategy. It has not yet completed any business combination, so it has not generated revenue from any products or services. NorthView Acquisition Corp. is structured to facilitate transactions that will create value for its shareholders through future business operations.

Frequently asked questions about Profusa

Converted at the current exchange rate, the Profusa share trades at 0.37 EUR (0.41 USD).

The Profusa share (PFSA) is listed on 1 stock exchanges, including: NASDAQ (NVAC).

The revenue cannot currently be calculated for Profusa.

The profit cannot currently be calculated for Profusa.

The P/E ratio cannot be calculated for Profusa at the moment.

The P/S cannot be calculated for Profusa currently.

The Eulerpool Quality Score for Profusa is 5/10.

The ISIN of Profusa is US74319X2071. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Profusa is PFSA. The ticker symbol is used to trade Profusa shares on the stock exchange.

Fair ValueTerminal
0.34 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Dec 20, 2021
ISIN
US74319X2071
Cusip
66718N103
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
302.48 %
Last updated Nov 18, 2026, 5:34 PM

Profusa Peer Group

Profusa Ticker

NASDAQ · NVAC

All fundamentals and in-depth analysis of Profusa

Our stock analysis for Profusa stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Profusa. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.